Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?
The NIH, which funded much of Moderna’s research on the COVID-19 vaccine, should be assertive in exerting control over the results of this research.

The NIH, which funded much of Moderna’s research on the COVID-19 vaccine, should be assertive in exerting control over the results of this research.

The ACLU mounted an unprecedented challenge the entire practice of gene patenting in America. And, against the odds, they won.

Jorge Contreras is joining Bill of Health as a regular contributor. He is a Presidential Scholar and Professor of Law at the University of Utah.